a, a N Clinical Trials
A listing of a, a N clinical trials actively recruiting patients volunteers.
Found 1922 clinical trials
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma
The names of the study drugs and vaccine involved in this study are:DC/MM fusion vaccine (a personalized cancer vaccine in which harvested participant tumor cells are fused with harvested participant dendritic blood cells)Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) (a type of growth factor)Elranatamab (a type of T-cell engager antibody)
- 0 views
- 27 Mar, 2026
- 2 locations
Auricular Acupressure for Premenstrual Syndrome in Female Students
This has led to increasing interest in alternative treatments such as traditional medicine. Auricular acupressure, a non-invasive and low-risk method, has shown promising results in managing PMS symptoms and is gaining attention as a possible solution.
- 0 views
- 26 Mar, 2026
- 4 locations
Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer (PSOAS)
However, the rehabilitation concept does not allow to improve muscular and functional reserves at the time of surgery. Sarcopenia is a condition characterized by loss of skeletal muscle mass and function. Also, the prevalence of sarcopenia in patients with cancer is high and has a prevalence of around 25% in …
- 0 views
- 24 Nov, 2025
- 1 location
Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas (CIRTUSARC)
The study is a Phase 2 clinical trial of the drug cirtuvivint as a second-line treatment for advanced soft tissue sarcomas. The study is being conducted in Spain and is expected to enroll approximately 25 patients in total.
- 0 views
- 24 Jun, 2025
- 1 location
Elranatamab in R/R Multiple Myeloma
This research is being done to see if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory multiple myeloma.
- 0 views
- 24 Nov, 2025
- 3 locations
TriPRIL CAR T Cells in Multiple Myeloma
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells.This research study involves the study drugs:.TriPRIL CAR T CellsFludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part …
- 0 views
- 24 Nov, 2025
- 1 location
Switch Maintenance in Pancreatic
This study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic cancer that has spread to other parts of body.This research study involves immunotherapy. Immunotherapy triggers the body's immune system to fight cancer cells.The names of the study drugs involved …
- 0 views
- 24 Nov, 2025
- 1 location
